강효정 교수(약학대학 약학과)
o (1998) B.A., Korea University, Seoul, Korea
o (2000) M.A.,Korea University, Seoul, Korea
o (2024) Ph.D., Texas A&M University, College Station, TX, USA
o (2022.04~Present) Professor, Kyungpook National University, Daegu, Korea
o (2017.04~2022.03) Associated Professor, Kyungpook National University, Daegu, Korea
o (2011.03~2017.03) Assistant Professor, Kyungpook National University, Daegu, Korea
o (2007.08~2011.02) Postdoctoral Researcher, The Wistar Institute, Philadelphia, PA, USA
o (2005.01~2007.08) Postdoctoral Researcher, Texas A&M Health Science Center, College Station, TX, USA
o (200.01~2004.12) Research Assistant, Texas A&M University, College Station, TX, USA
0 Epstein-Barr virus pathogenesis and oncogenic mechanisms
0 Oncolytic virotherapy development
0 Coronavirus replication and gene expression
0 Epigenetic mechanisms in cancer and drug development
1) Epstein-Barr Virus (EBV) Pathogenesis and Oncogenic Mechanisms:
o Elucidating the molecular mechanisms underlying EBV-induced pathogenesis and oncogenesis.
o Investigating the role of epigenetic modifications, particularly DNA methylation, in EBV-associated cancers.
o Identifying and characterizing novel CTCF binding sites in the EBV genome and their impact on viral gene expression and host cell
transformation.
2) Oncolytic Virotherapy Development:
o Developing and evaluating oncolytic viruses based on adenovirus and HSV-1 platforms for cancer treatment.
o Targeting viral lytic genes and optimizing therapeutic efficacy and safety of oncolytic viruses.
3) Coronavirus Replication and Gene Expression:
o Investigating the molecular mechanisms of coronavirus replication, including the role of 5'UTR stem-loop structures.
o Understanding the regulation of subgenomic RNA production in coronaviruses.
4) Epigenetic Mechanisms in Cancer and Drug Development:
o Elucidating the role of epigenetic modifications, such as DNA methylation, in cancer development and progression.
o Developing novel therapeutic strategies Targeting epigenetic regulators for cancer treatment.